Pharma Focus Europe-Newsletter
Pharma Focus Europe
Pharma Focus Europe is a Bi-Annual publication from Ochre Media Pvt. Ltd.
Latest Articles
Selecting the right pharmaceutical publisher plays a vital role for any research going into publication in Europe’s rapidly growing pharma market environment. Based on this study, it is possible to define 10 criteria, which would allow the selection of the most suitable publishers for the given material, such as compliance with legal requirements, the impact factor, language translation, and other aspects of ethical behavior.
Print media, particularly magazines, continue to offer a valuable way of reaching a well-inspected, informed audience, mostly within the pharma sector. Ultimately, through identifying the audience, telling great stories, applying effective visual design, linking campaign types of both print and online, and employing the big data approach, businesses can achieve the maximum of their return on investment (ROI). Strategic planning leads to excellent and complaint ad campaigns that are most effective and inventive.
mRNA technology changes mankind in vaccine development and expands to cancer, genetic disorders, rare diseases, and regenerative medicine. Its possibilities are in cardiology, immunity, and individualized treatment. Issues such as delivery and stability are being addressed, making it possible for a revolution in health care that will address various health problems through the invention of specific therapies.
Expert Interviews
Author: Gillian Woollett, and Head of Regulatory Strategy and Policy, Samsung Bioepis
How is innovation driving the development of novel biopharmaceuticals and biosimilars?
Just like with any other industry, biotech relies on new products replacing old—the virtuous cycle. The competition from biosimilars nibbles at the heels of the originators, and they innovate to create novel options as biosimilars replace older biologics with competitive versions that improve access and affordability. Known as the Virtuous Cycle
Author: Ryan Mills, Senior Director, Denali Therapeutics
Clinical trials are a critical part of the pharmaceutical development process. These trials cannot proceed without timely and regular receipt of the drugs being tested, which can prove a challenge for drug manufacturers who have not yet established the structures required to produce quality-controlled specimens of the drug at scale. Managing supply chains of pre-production drugs for clinical trials is therefore an essential component of drug development.
Author: Mike Cioffi, Senior Vice President of Clinical Solutions and Strategic Partnerships, WCG, & Anna Worsley, CEO of FABRX-AI and Director of Innovation, FABRX
In recent years, the pharmaceutical industry has increasingly shifted its focus toward patient-centric drug development. This approach aims to integrate the needs, preferences, and experiences of patients into every stage of the drug development lifecycle, from early research to post-market studies. With innovations in technology, regulatory changes, and growing patient advocacy, the industry is exploring how best to deliver therapies that truly align with patient outcomes.
Industrial Events
Industrial Projects
Novo Nordisk has revealed plans to invest 8.5 billion Danish kroner in the construction of a new production facility in Denmark. This marks the first time in this century that the company has launched a new production site in Denmark.
领英推荐
Ardena has invested €20 million in expanding its nanomedicine manufacturing facility in the Netherlands, achieving full Good Manufacturing Practice (GMP) certification.
The Latest Tech Innovations
Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation for Trodelvy? (sacituzumab govitecan-hziy) in the treatment of adult patients with extensive-stage small cell lung cancer (ES-SCLC)
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to tolebrutinib for the treatment of adults with non-relapsing secondary progressive multiple sclerosis (nrSPMS).?
HUTCHMED has announced that the Center for Drug Evaluation of China’s National Medical Products Administration (NMPA) has granted breakthrough therapy designation (BTD) to the combination of ORPATHYS? (savolitinib) and TAGRISSO? (osimertinib) for treating patients
Most Engaging Articles
AI is transforming drug discovery, slashing the time and cost to develop new medicines. Recently, cutting-edge AI tools are uncovering drug targets faster, refining potential therapies, and predicting safety with remarkable precision.
Author: Akshay Peer, Senior Vice President, Product Development and a Co-founder of TrakCel
In this article, Dr. Akshay Peer, TrakCel’s Senior Vice President Product, explores the evolving challenges of cell and gene therapy orchestration and the critical role of technology in streamlining processes, ensuring patient safety, and promoting standardization.
Authors: Carl Schoellhammer, Associate Partner, DeciBio, Cassidy Humphreys, Senior Analyst, DeciBio; and Aditi Ghalsasi, Analyst, DeciBio
The mRNA field is maturing beyond pandemic-era vaccines, requiring strategic focus on therapeutic applications beyond infectious diseases. Challenges like improving delivery vehicles and advancing in vivo cell therapies are key to unlocking mRNA’s potential. As the market evolves, finding the right niche are critical for future success
Press Releases
?????? ???????????? ???????????????? ?????????? ???????????????? ?????????????????? ??????????????, ???????????? ????????????????, ???????????????? ?????????????? ?????? ???????????? ?????????????? ???? ?????? ???????????????????????????? ???????????? ??????'?? ???????? ????! https://www.pharmafocuseurope.com/magazine
?????????? ?????? ??????????????: https://www.pharmafocuseurope.com
?????????????????? ???????? ???? ?????????????? ?????? ???????? ???????????? ??????????????: https://www.pharmafocuseurope.com/subscribe
?????????????? ?????? ???????????????? ????????????: https://www.pharmafocuseurope.com/archives
???????????????????? ???? ?????????????????????? ???????? ???????????? ?????????? ????????????? ???????????????? ?????? ?????????? ???????? ????????: https://www.pharmafocuseurope.com/advertise